by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Sato Pharmaceutical Co., Ltd. Warning Letter Details

Warning Letter

Sato Pharmaceutical Co., Ltd.

Sato Pharmaceutical Co., Ltd., 1-5-27 Moto-Akasaka Minato-ku Tokyo 107-0051 Japan

Issue DateMay 18, 2026

FEI Number3004055563

Violations4

CountryJapan

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/Drugs/Adulterated/OTC

Sato Pharmaceutical Co., Ltd. FDA Warning Letter, May 18, 2026